Q2 2024 Holdings
Filed 2024-08-14 | 85 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $1.9K | 12,136 | 0.0% |
| Caremax Inc | CL A NEW | 14171W202 | $59.1K | 21,200 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $1.0M | 1,188,178 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.7M | 350,000 | 0.1% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.8M | 2,018,500 | 0.1% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $2.9M | 1,448,728 | 0.1% |
| Kezar Life Sciences Inc | COM | 49372L100 | $3.0M | 5,026,000 | 0.1% |
| AC Immune SA(ACIU) | SHS | H00263105 | $3.3M | 825,000 | 0.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $3.6M | 694,000 | 0.2% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $3.8M | 117,000 | 0.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $3.8M | 170,000 | 0.2% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $3.8M | 816,000 | 0.2% |
| Arca Biopharma Inc(ABIOEUR) | COM | 00211Y506 | $3.8M | 1,000,000 | 0.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $4.4M | 93,000 | 0.2% |
| Immatics N.v(IMTX) | SHS | N44445109 | $4.6M | 393,100 | 0.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $4.6M | 195,000 | 0.2% |
| Uipath Inc(PATH) | CL A | 90364P105 | $4.6M | 362,000 | 0.2% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $6.0M | 373,000 | 0.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $6.8M | 200,000 | 0.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.4M | 1,000,706 | 0.4% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $8.6M | 1,673,538 | 0.4% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $9.5M | 34,884,000 | 0.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $9.8M | 215,600 | 0.4% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $9.9M | 8,902,972 | 0.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $10.6M | 873,891 | 0.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $10.7M | 559,300 | 0.5% |
| Privia Health Group Inc(PRVA) | COM | 74276R102 | $13.3M | 764,200 | 0.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $14.3M | 338,500 | 0.6% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $14.9M | 7,419,355 | 0.6% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $15.2M | 1,300,064 | 0.6% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $15.3M | 315,000 | 0.6% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $15.6M | 450,000 | 0.7% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $15.7M | 343,200 | 0.7% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $16.0M | 205,000 | 0.7% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $16.7M | 1,620,000 | 0.7% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $17.5M | 255,000 | 0.7% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $17.6M | 398,000 | 0.7% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $17.7M | 1,800,000 | 0.8% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $17.8M | 782,000 | 0.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $19.2M | 487,000 | 0.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $21.4M | 284,000 | 0.9% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $23.3M | 290,000 | 1.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $23.7M | 1,100,000 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $24.0M | 908,000 | 1.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $24.1M | 531,000 | 1.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $25.0M | 731,104 | 1.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $26.0M | 60,500 | 1.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $26.5M | 727,537 | 1.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $26.5M | 224,000 | 1.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $27.2M | 1,559,826 | 1.2% |